Posted on March 30, 2023 |
The Craneware Group (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today publicly announces it supports and underwrites the advocacy group 340B Matters. In 2016, guided by ...
Posted on March 15, 2023 |
By 340B Matters Greed and political expediency can lead to the darkest places. Take the new group ASAP340B, an ungodly confederation of Big Pharma, Community Health Centers and a handful of ...
Posted on February 07, 2023 |
By 340B Matters The drug industry hates the 340B Drug Discount Program because it forces them to sell drugs at a lower cost to qualified non-profit health providers. So, to ...
Posted on January 17, 2023 |
“The 19 drug companies that have imposed restrictions on safety-net hospital access to 340B drug pricing program discounts collectively brought more than $660 billion in revenues in 2021. The banner ...
Posted on January 12, 2023 |
“A federal court has ruled it’s up to the HHS to determine how to repay hospitals enrolled in the 340B drug discount program after years of underpayments, sparking concern from ...